Shopping Cart
Remove All
Your shopping cart is currently empty
NSC-319726 (ZMC1), a mutant p53R175 reactivator, suppresses growth of fibroblasts that expresses the p53R175 mutation (IC50 = 8 nM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $32 | In Stock | In Stock | |
| 5 mg | $52 | In Stock | In Stock | |
| 10 mg | $85 | In Stock | In Stock | |
| 25 mg | $159 | In Stock | In Stock | |
| 50 mg | $288 | In Stock | In Stock | |
| 100 mg | $490 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $57 | In Stock | In Stock |
| Description | NSC-319726 (ZMC1), a mutant p53R175 reactivator, suppresses growth of fibroblasts that expresses the p53R175 mutation (IC50 = 8 nM). |
| Targets&IC50 | p53 (R175):8 nM |
| In vitro | In cells with mutant p53, NSC319726 (IC50=8 nM) causes a WT-like conformational change in the mutant protein that repairs sequence-specific p53 transcription. |
| In vivo | In cells with mutant p53, NSC319726 (IC50=8 nM) causes a WT-like conformational change in the mutant protein that repairs sequence-specific p53 transcription. |
| Kinase Assay | MTS: 5,000 cells of TOV112D cells (5,000 cells/well, in 100 ml culture) are cultured in 96-well plate to reach the 50%–60% confluence on the second day when treated with serial dilutions of the compounds. The growth is measured by MTS reagent and Victor Plate reader instrument after incubation for 3 days. |
| Cell Research | Viability assays are done. The cells (5×104 cells/well, in 1 ml culture) are cultured in a 12-well plate to reach the 50%–60% confluence on the second day when treated with serial dilutions of the compound. The growth is measured by Guava ViaCount reagent and Guava PCA instrument after incubation for 3 days.(Only for Reference) |
| Molecular Weight | 234.32 |
| Formula | C11H14N4S |
| Cas No. | 71555-25-4 |
| Smiles | C\C(=N/NC(=S)N1CCC1)c1ccccn1 |
| Relative Density. | 1.26g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: 2.3 mg/mL (9.82 mM), Heating is recommended. DMSO: 23.4 mg/mL (99.86 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (8.54 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.